ClinicalTrials.Veeva

Menu

Probiotics to Promote Intestinal Health

The Washington University logo

The Washington University

Status and phase

Completed
Phase 4

Conditions

Infection
Pharmacologic Actions
Anti-Infective Agents
Therapeutic Uses
Communicable Diseases

Treatments

Other: Placebo
Dietary Supplement: Probiotic

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02046512
CK000162-aim3 (Other Grant/Funding Number)
201310102

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on broad spectrum antimicrobials.

Enrollment

89 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ≥ 18 years old
  • Admission to the non-ICU medical and surgical wards
  • On broad spectrum antimicrobials with an anticipated length of stay of >48 hours

Exclusion criteria

  • Pregnancy
  • Non English speaking
  • Expected to die within 7 days
  • Unable or unwilling to consent
  • HIV infection with a CD4 count <200
  • Neutropenia with an absolute neutrophil count less than 500 cells/ml (or expected to drop to less than 500)
  • Clinically significant diarrhea or history of C. difficile infection in the last 3 months
  • History of VRE colonization and/or infection in the last year
  • Transplant recipients

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

89 participants in 2 patient groups, including a placebo group

Probiotic
Experimental group
Description:
Patients randomized to probiotic therapy will receive 1 capsule containing 10 billion cells of Lactobacillus rhamnosus GG on a twice-daily basis
Treatment:
Dietary Supplement: Probiotic
Sugar Pill
Placebo Comparator group
Description:
Patients randomized to placebo therapy will receive an identical appearing placebo capsule on a twice-daily basis
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems